US Edition
Extracellular Vesicle-Derived gD Protein Vaccine Platform: A Novel Approach to Developing Highly Preventive Vaccines against HSV1/2 Infection and Tumor Metastasis
Summary by researchsquare.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Extracellular Vesicle-Derived gD Protein Vaccine Platform: A Novel Approach to Developing Highly Preventive Vaccines against HSV1/2 Infection and Tumor Metastasis
Although no vaccines are currently available for HSV infection, the development pipeline is rich with candidates in various phases of preclinical and clinical trials. In this study, we introduced a novel preventive vaccine platform based on extracellular vesicles (EVs), representing a signific...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
